The acquisition strengthens Argenta’s 'molecule to market' strategy and integrated value proposition for customers

LONDON, October 15, 2024 – Argenta, the leading animal health pharmaceutical services company, today announced that it has closed on the carve-out acquisition of the manufacturing site and operations in Shawnee, Kansas, USA from TriRx Pharmaceuticals, LLC.

As part of the Argenta platform, the world-class Shawnee facility will continue to operate as a leading provider of end-to-end CDMO services to the animal health industry. With a well-rounded set of capabilities including sterile fill-finish, non-sterile liquids and pastes, and oral solid dose – the site is ideally-positioned to continue growing with existing strategic customers as well as new potential clients who are looking for a reliable partner to help develop and manufacture their in-market portfolios and future pipeline products.

“The Shawnee site is a state-of-the-art facility with a strong legacy and track record of innovation, quality, and customer delivery” said Kugan Sathiyanandarajah, Partner at KKR and Board Member at Argenta. “With a comprehensive set of innovative capabilities including market-leading expertise in sterile fill-finish technology, we believe the Shawnee site is extremely well-positioned in the market for further growth and expansion.”

“We have long admired the team and operations at the Shawnee site and believe this is a transformational addition to our platform at Argenta. With our ability to now offer a truly end-to-end service for customers across the value chain combined with our dedicated and intentional focus towards serving the animal health industry – we believe we have a unique opportunity to become the clear, go-to strategic partner for customers in our ecosystem,” said Johnny Kim, Director at KKR and Board Member at Argenta.

‍

About Argenta

Argenta is a global animal health services company, supporting companies big and small to develop and manufacture products that contribute to the health and well-being of animals. From 'molecule to market', our trusted, innovative solutions cover every stage of product development and we are trusted by the world’s top animal health companies – who return to Argenta for our unparalleled, comprehensive support. For more information, please visit www.argentaglobal.com.

‍

Press Contact

Annemieke.dekeijzer@argentaglobal.com